Jpmorgan Chase & CO Abiomed Inc Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $45.7 Million - $56.8 Million	-188,471 Reduced 46.36%	218,051 $53.6 Million
Q2 2022 Aug 11, 2022	BUY	$224.73 - $338.64 $5.71 Million - $8.61 Million	25,430 Added 6.67%	406,522 $101 Million
Q1 2022 May 11, 2022	SELL	$277.25 - $366.29 $28 Million - $37 Million	-100,997 Reduced 20.95%	381,092 $126 Million
Q4 2021 Feb 10, 2022	SELL	$300.63 - $371.35 $21.8 Million - $27 Million	-72,604 Reduced 13.09%	482,089 $173 Million
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $172 Million - $209 Million	554,693 New	554,693 $181 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.